Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 28, 2015 10:43 AM ET

Life Sciences Tools and Services

Company Overview of SeraCare Life Sciences, Inc.

Company Overview

SeraCare Life Sciences, Inc. provides products and services to facilitate the discovery, development, and production of human and animal diagnostics, and therapeutics. The company’s Diagnostic and Biopharmaceutical Products segment offers controls and panels for the evaluation and quality control of infectious disease tests in clinical laboratories, blood banks, and in vitro diagnostic (IVD) manufacturing; and reagents and bioprocessing products for use in the discovery, development and manufacturing processes for drugs, vaccines, and diagnostic tests. It also provides diagnostic intermediates for use in manufacturing diagnostic test kits; cell culture additives and media that maintain viabi...

37 Birch Street

Milford, MA 01757

United States

Founded in 1984

193 Employees

Phone:

508-244-6400

Fax:

508-634-3394

Key Executives for SeraCare Life Sciences, Inc.

Chief Executive Officer and President
Chief Financial Officer and Secretary
Age: 66
Vice President of Human Resources
Age: 57
Controller
Vice President of Manufacturing Operations
Age: 59
Compensation as of Fiscal Year 2014.

SeraCare Life Sciences, Inc. Key Developments

SeraCare Life Sciences Introduces New Accuspan Molecular Linearity Panels

SeraCare Life Sciences announced seven new AccuSpan(TM) molecular linearity panels for the detection of Adenovirus (ADV), Varicella Zoster Virus (VZV), JC Virus (JCV), Herpes Simplex Virus 1 (HSV1), Herpes Simplex Virus 2 (HSV2), Epstein Barr Virus (EBV), and BK Virus (BKV). These new linearity panels from SeraCare help assay developers thoroughly challenge their transplant assays from extraction phase through amplification. Each panel consists of four members: one negative, one low positive, one medium positive, and one high positive sample. These panels are provided in a ready-to-go single-use format with target concentrations that cover the dynamic range of most molecular assays and are consistent within each lot and across batches.

SeraCare Life Sciences Introduces New ACCURUN(R) C. difficile Control Set

SeraCare Life Sciences, Inc. announced the launch of its new ACCURUN(R) 501 C. difficile Control -- the company's first molecular control product targeting hospital acquired infections. ACCURUN 501 C. difficile Control is formulated for use with in vitro diagnostic tests that detect C. difficile DNA in human stool samples. Manufactured from cultured Clostridium bacteria of four different strains or species delivered in a set of four vials, the bacteria are inactivated and in a human synthetic stool matrix. The control is ready-to-use in assays that detect C. difficile DNA with any transport system.

SeraCare Life Sciences Expands Genetic Portfolio with New Accurun(R) Product

SeraCare Life Sciences announced the launch of its new ACCURUN(R) 611 product, a robust product that demonstrates consistent performance over time. This reference material is designed to support detection of the Factor V Leiden mutation and the Factor II gene variant, as well as mutations in the Methlyenetetrahydrofolate reductase (MTHFR) gene that are associated with significant health problems. ACCURUN(R) 611 meets the needs of a broad range of molecular lab applications by providing heterozygous, mutant, or wild type scores for Factor II, Factor V, and MTHFR. It is ready-to-use genomic DNA manufactured from immortalized Peripheral Blood Mononuclear Cells (PBMCs) derived from human samples. Mutations were confirmed by a variety of commercial SNP genotyping assays, providing a robust challenge for all mutations in only two vials.

Similar Private Companies By Industry

Company Name Region
Avid Bioservices, Inc. United States
Clinical Research Consulting LLC United States
Molecular Response, LLC United States
Covance Clinical Research Unit, Inc. United States
Extera Partners, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SeraCare Life Sciences, Inc., please visit www.seracare.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.